COMBINATION OF ERLOTINIB AND GLUTAMINASE INHIBITOR FOR TREATING LUNG CANCER

摘要

The invention relates to a method of treating or preventing cancer, comprising conjointly administering a glutaminase inhibitor and erlotinib, wherein cancer is lung cancer and the glutaminase inhibitor is a compound of formula Ia; ;or a pharmaceutically acceptable salt thereof. The invention also relates to a pharmaceutical composition for treating lung cancer, comprising a glutaminase inhibitor and erlotinib, wherein the glutaminase inhibitor is a compound of formula Ia. The invention provides the improved treatment of lung cancer.